Rendering of the planned building at 400 Summer St. (WS Development)
September 23, 2021 10:32 AM EDTUpdated 10:51 AM
Pharma

Roche's Foun­da­tion Med­i­cine is get­ting a new 16-sto­ry home in Boston's Sea­port Dis­trict

Paul Schloesser

Associate Editor

A de­vel­op­er and an in­vest­ment firm have joined to­geth­er to add yet an­oth­er biotech build­ing to Boston’s sky­line. And to­day, a pri­vate eq­ui­ty firm has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

No­vo Nordisk CEO to step down, time­line for suc­ces­sor un­known

'Go ahead and do it': Top RFK Jr. deputy dares drug­mak­ers that might pull man­u­fac­tur­ing over new price pres­sure

No­vo Nordisk’s glob­al obe­si­ty leader is mov­ing on; Flag­ship biotech gets CEO from Schol­ar Rock

The in­side sto­ry of the six-month sprint to cre­ate the first cus­tom CRISPR ther­a­py for one in­fant’s rare dis­ease

It's been three months with­out a biotech IPO

RFK Jr. adopts new chikun­gun­ya vac­cine guid­ance; oth­er rec­om­men­da­tions re­main un­der re­view

A service from the Financial Times